Oral curcumin for Alzheimer's disease: tolerability and efficacy in a 24-week randomized, double blind, placebo-controlled study

2012513 citationsJournal Articlegold Open Access

Authors

ClinicalTrials.gov Identifier: NCT00099710.

Good health and well-being

Published in: Alzheimer s Research & Therapy

Volume 4, Issue 5, pp. 43-43

Field-Weighted Citation Impact: 11.66